Today: 1 July 2026
Browse Category

NYSE:ELV 21 October 2025 - 10 January 2026

UnitedHealth stock rises as lawmakers summon insurers; UNH earnings date now in focus

UnitedHealth stock rises as lawmakers summon insurers; UNH earnings date now in focus

New York, Jan 8, 2026, 20:57 — Market closed U.S. House lawmakers have called on UnitedHealth Group Incorporated and four other major insurers to testify on coverage affordability later this month, signaling growing Washington scrutiny. UnitedHealth shares rose 1.5% to close at $346.85 on Thursday. The House Energy and Commerce Committee and the Ways and Means Committee extended invitations to UnitedHealth, CVS Health, Cigna, Elevance and Ascendia for testimony on Jan. 22. Reuters
9 January 2026
·····
UnitedHealth Group Incorporated stock rises as House summons insurer CEOs; investors eye two January dates

UnitedHealth Group Incorporated stock rises as House summons insurer CEOs; investors eye two January dates

New York, January 8, 2026, 13:30 — Regular session UnitedHealth Group Incorporated shares rose on Thursday after U.S. House lawmakers invited the CEOs of major health insurers to testify on January 22 about coverage affordability, as Republicans debate whether to extend Affordable Care Act subsidies and President Donald Trump has said he plans to meet insurers. The stock was up 1.3% at $346.11 by early afternoon, after trading between $339.99 and $347.79. CVS Health, Cigna and Elevance Health, also named for the hearing, were higher. Reuters
8 January 2026
····
Artisan Value Fund reveals why it dumped Cigna for Elevance — and why ASML stays a top bet

Artisan Value Fund reveals why it dumped Cigna for Elevance — and why ASML stays a top bet

Artisan Partners’ Artisan Value Fund said in its third-quarter 2025 investor letter that it sold The Cigna Group and bought Elevance Health, citing rising policy risk around pharmacy benefit managers. The fund also reiterated conviction in ASML Holding, keeping the chip-equipment maker among its top positions. Insider Monkey The portfolio shifts land as investors look for signs that the market’s leadership can broaden beyond AI-linked winners. They also underscore how quickly regulatory scrutiny can reshape the outlook for big healthcare intermediaries.
31 December 2025
····
Elevance Health Stock (NYSE: ELV) News Today: Credit Ratings, ACA Subsidy Vote, and Analyst Forecasts on Dec. 12, 2025

Elevance Health Stock (NYSE: ELV) News Today: Credit Ratings, ACA Subsidy Vote, and Analyst Forecasts on Dec. 12, 2025

Elevance Health, Inc. is drawing fresh investor attention on December 12, 2025 as credit-rating updates and U.S. policy headlines collide with a stock that has recently rebounded sharply. The latest developments arrive at a sensitive moment for managed-care names, with Wall Street weighing medical-cost trends, Medicaid rate dynamics, and the looming Affordable Care Act subsidy deadline. As of Friday’s latest trade, ELV stock was around $360, after swinging between the day’s high and low in moderately active trading.
12 December 2025
·
Elevance Health (ELV) Stock: December 2025 Outlook After Q3 Earnings Beat, Legal Headwinds and New Analyst Targets

Elevance Health (ELV) Stock: December 2025 Outlook After Q3 Earnings Beat, Legal Headwinds and New Analyst Targets

As of early December 3, 2025, Elevance Health, Inc. is trading around $331 per share, leaving the managed-care giant roughly 30% below its 52‑week high near $459, even after a strong third‑quarter earnings beat and renewed institutional buying.Investing.com+1 Over the past 12 months the stock is down about 18%, significantly lagging the S&P 500.PortfoliosLab This article pulls together the latest news, forecasts and analysis available as of December 2, 2025, to give a comprehensive view of where Elevance Health stock stands now and what markets are pricing in for 2026 and beyond.
3 December 2025
·
Elevance Health Stock Soars on Massive Q3 Earnings Beat – What It Means for Investors

Elevance Health Stock Soars on Massive Q3 Earnings Beat – What It Means for Investors

Elevance Health posted strong third-quarter 2025 results, significantly outperforming market expectations on both profit and revenue. Adjusted earnings came in at $6.03 per share, well above the ~$4.95 analysts predictedinvesting.com. Likewise, revenue for the quarter reached $50.1 billion, surpassing the $49.3 billion consensus and growing 12% year-over-yearinvesting.com. This robust growth was fueled by higher premium yields and an expanding customer base – particularly gains in Medicare Advantage enrollments – along with contributions from recent acquisitions in Elevance’s Carelon health services unittradingview.com. These factors combined to help Elevance smash its Q3 forecasts, showcasing strong demand and pricing power in its health benefits business. Investors reacted enthusiastically to the earnings news. Elevance’s stock price surged in pre-market trading, rising over 7% before the market opened Tuesdayreuters.com. The rally signaled relief and optimism that the company’s performance is outpacing expectations despite cost pressures. Upon the market open, ELV shares hovered in the mid-$350s – roughly flat versus Monday’s close, as some early gains moderated. Even so, the stock was still up about 15% from a month earliersimplywall.st, reflecting building momentum ahead of the results. The upbeat Elevance report also gave a jolt to other health insurers: UnitedHealth Group and Centene saw their stocks
21 October 2025
····
1 2

Stock Market Today

  • Sensex, Nifty Edge Up as Auto Leads, Rainfall Deficit Caps Gains
    July 1, 2026, 1:22 AM EDT. The BSE Sensex added 181.28 points to 76,659.95 and NSE Nifty50 rose 49.90 points to 23,915.65, lifted by auto stocks but held back by a 40% rainfall deficit in June and a lack of progress in US-Iran talks. Sector action was mixed - Nifty Media up 1.63%, Nifty Metal down 0.72%. Among major Sensex players, Mahindra & Mahindra gained 2.05%, Titan added 1.44%. Bajaj Finserv lost 2.13%. Crude hovered near $73 a barrel, helping inflation views, but market tone turned cautious on geopolitics. Analysts pointed to monsoon deficiencies as an increasing drag on the farm sector and economy.
Go toTop